38 filings
Page 2 of 2
8-K
usiytv
9 May 23
Amgen and Tscan Therapeutics Announce Collaboration to Identify Novel Targets In Crohn’s Disease
9:15am
8-K
2m9h r5dd5ohvthfern
10 Apr 23
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
7:45am
8-K
tkum b2uloda6s3z
31 Mar 23
Tscan Therapeutics Announces Ceo Transition
8:57am
8-K
sq4q27e 84y2wdbtg
8 Mar 23
TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
7:15am
8-K
sjc1b2wn3i2ga2033r
23 Jan 23
TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors
7:06am
8-K
746sj6p5uzgn59kscvd
9 Nov 22
TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
7:06am
8-K
a8414do2umk63ryzq
12 Sep 22
TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
7:51am
8-K
webxbp5
10 Aug 22
TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
12:00am
8-K
0xyo9 jrw
7 Jul 22
Departure of Directors or Certain Officers
7:11am
8-K
itbbcd4
3 Jun 22
Departure of Directors or Certain Officers
4:03pm
8-K
sxrc55zqw be42rn7
31 May 22
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies
7:07am
8-K
g7qw1lupsfgmvta
9 May 22
TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones
7:08am
8-K
fxqh6201owertbd6h
9 Mar 22
TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities
7:13am
8-K
ssi7wiw0
24 Jan 22
TScan Therapeutics Announces FDA Clearance of Investigational New Drug
7:31am
8-K
mtb74o 737g
2 Dec 21
Entry into a Material Definitive Agreement
7:31am
8-K
825k688
10 Nov 21
TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
7:02am
8-K
yw9r6oearvq4fd4pwui
19 Aug 21
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
7:15am
8-K
wp3hysialro2ubebq
20 Jul 21
Departure of Directors or Certain Officers
4:36pm